The role of ACE inhibitors and ARBs in the treatment of COVID-19 has been a key topic for researchers since the pandemic began. This latest research represents a significant update for clinicians. 

After athletes recover from COVID-19, when can they get back to their regular schedules? CMR imaging seems as if it will play a key role when it comes to making such decisions. 

In a new analysis, researchers highlighted IVL’s potential for helping with the treatment of coronary artery disease.

The combination of inflammation and thrombosis is crucial, suggesting that endothelial dysfunction could be at the heart of this complex infection.

“We think we’ve found a way to quiet that inflammatory environment, giving stem cells a chance to survive and do the healing work we know they can do,” one researcher said. 

The savings are a direct result of clinicians prescribing generic formulations whenever possible. 

The study's authors tracked 450 patients with uncontrolled high blood pressure.

The dozens of faculty members include physicians, researchers, epidemiologists and health policy experts, who voiced their concerns in a letter shared.